-

    .

Nanotechnologies for precision medicine

     
   11 Sept. clessidra che gira 16:00 - 17:30
 ROOM 7
energy
YOUNGINNOVATION
THE STATE OF RESEARCH COMMUNICATED BY YOUNG RESEARCHERS
TT.IV Technical Multi-Track with Parallel SYMPOSIA
Nanotechnologies for precision medicine
Co-organized with University Magna Graecia of Catanzaro
in cooperation with SIRTEPS e SITELF
sirteps sitelf
Chair: Maria Chiara CRISTIANO, University Magna Graecia of Catanzaro

The topic "Nanotechnologies for precision medicine" explores the integration of nanotechnologies in the field of personalized medical care. It delves into how nanoscale materials and techniques are harnessed to reshape diagnostics, therapies, and treatments to tailor them to each patient's unique characteristics. By harnessing the distinctive properties of nanomaterials, this field is paving the way for more targeted and effective interventions, ranging from disease detection and drug delivery to innovative therapies such as gene editing and RNA interference. However, this convergence of nanotechnology and medicine also presents challenges, such as regulatory considerations and toxicity issues, that need to be addressed for sustainable implementation. Ultimately, the evolving landscape of nanotechnology in precision medicine promises a future in which healthcare is fine-tuned to individual profiles, ushering in a new era of personalized and improved medical outcomes.

The symposium is part of the SE.I
TT.IV.H.1
SE.I.7.1
Introductive Keynote
Marco MONOPOLI - CV
Royal College of Surgeons, Ireland | European Technology Platform on Nanomedicine (ETPN Association)
Understanding the nanomaterial interaction with biomolecules, a journey from safety to applications in modern medicine
!NEUTRO PPT eceded
TT.IV.H.2
SE.I.7.2
Ruchi VYAS - CV
University of Rajasthan
Magnetic Nanobeads based Lateral flow assay for early detection of traumatic brain injury
!NEUTRO PPT eceded
TT.IV.H.3
SE.I.7.3
Lorenzo SARDELLI - CV
University of Turin
Mucosomes: bioinspired nanoparticles of glycosylated mucins to re-think mucosal drug delivery
!NEUTRO PPT eceded
TT.IV.H.4
SE.I.7.4
Alessandro PARADISI - CV
University of Modena and Reggio-Emilia
Carbon Nanotubes/Protein Hybrids for Healthcare Biosensing Applications
!NEUTRO PPT eceded
TT.IV.H.5
SE.I.7.5
Miriam CAVIGLIA - CV
ISS
Copper complexes with biological active molecule amantadine as potential anticancer and antiviral agents
!NEUTRO PPT eceded
 

 

 
freccia SX f54 Back to Fields & Topics Back to Plan 11 September freccia DX f54
 

 

INFO & CONTACTS

Dr. Federica SCROFANI

Tel. +39 06 49766676
Mob. +39 339 7714107
email: This email address is being protected from spambots. You need JavaScript enabled to view it.